See All Slides - tctmd.com

Slides

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara

October 12, 2015

$Median Nerve Neuromodulation: A Novel Approach to Refractory Hypertension (Valencia Technologies)$

Presentation TCT 2015

Median Nerve Neuromodulation: A Novel Approach to Refractory Hypertension (Valencia Technologies)

Presenter: Dave Peterson

October 13, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 5: Predominant Aortic Regurgitation

Presenter: Martin B. Leon, Neil E. Moat, Hendrik Treede

October 11, 2015

Presentation TCT 2015

Predominant or Isolated AR and TAVR: Thoughtful Commentary on the Case

Presenter: D. Craig Miller, Alec S. Vahanian, Hendrik Treede

October 12, 2015

Presentation TCT 2015

TCT 31: Immediate and 1-Year US IDE Trial Results of the New GORE CARDIOFORM Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects

Presenter: John P. Cheatham, Carlos Pedra, Joseph Paolillo

October 13, 2015

Presentation TCT 2015

PREMIUM Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

LV to Aorta Pumping: HeartMate PHP

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TVT 2013

Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention

Presenter: Anita Asgar

June 13, 2013

Presentation TVT 2013

Potential Complications of the MitraClip Procedure

Presenter: Scott Lim

June 13, 2013

Presentation TVT 2013

A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors

Presenter: Marco Barbanti

June 13, 2013

Advertisement

Slides

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Median Nerve Neuromodulation: A Novel Approach to Refractory Hypertension (Valencia Technologies)

Status Updates on New TAVR Indications 5: Predominant Aortic Regurgitation

Predominant or Isolated AR and TAVR: Thoughtful Commentary on the Case

TCT 31: Immediate and 1-Year US IDE Trial Results of the New GORE CARDIOFORM Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects

PREMIUM Trial: Lessons Learned

LV to Aorta Pumping: HeartMate PHP

Cardiogenic Shock due to Severe Ischemic Mitral Regurgitation: MitraClip Therapy as a Bridge to Surgical Intervention

Potential Complications of the MitraClip Procedure

A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content